Clinical testing and post-market surveillance are critical pieces of the vaccine product development process; however, in the undeveloped and developing worlds medical infrastructure does not exist to support the diagnostic testing prevalent in developed economies. Therefore, Global Vaccines believes there is another ideal opportunity for its unique business model. Using ample university developments, it stands to reason that Global Vaccines can revolutionize the vaccine testing industry just as it aims to revolutionize the vaccine administering industry.

In order to accomplish this we are developing a project called VaxDx (vaccine diagnostics). This project will begin by performing the due diligence necessary to prove the critical nature of diagnostic testing to the vaccination process, then launch into a strategic plan applying the current Global Vaccines business model to the diagnostics sector.  We hope to bring the highest amount of awareness not only to the administering of vaccinations, but to the entire process necessary in the developing world.

(Click here for details of the Global Vaccines Business model)

VaxDx activities are targeted to making it easier to test transformational new vaccines in undeveloped and developing world settings.  These new vaccines have the potential to save millions or even billions of lives

Important Note:  Clicking the funding link will open a new window to the GuideStar secure contributions web site.  GuideStar is a nonprofit organization that validates and assists other nonprofit organizations in fulfilling their missions. If you wish to contribute to this project, please enter "VaxDx" in the Designation section of the GuideStar page.